A Clinical Study of SHR-4394 in Combination With Anti-tumor Therapy in Prostate Cancer

Clinical trial NCT07407283 · RECRUITING

Trial details

NCT number: NCT07407283
Sponsor: Jiangsu HengRui Medicine Co., Ltd.
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2026-04-08
Primary completion: 2027-11-01
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.